{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:30:07Z","timestamp":1782592207595,"version":"3.54.5"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T00:00:00Z","timestamp":1681516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Lipids Health Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The long-term excessive intake of exogenous cholesterol can lead to abnormally elevated blood lipid levels and induce cardiovascular and cerebrovascular diseases. However, the influence and relevance of exogenous cholesterol on plasma cholesterol components were still unclear, and the influence on intestinal lipid metabolism targets needs to be further explored.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In vivo, the C57BL\/6\u2009+\u2009NF group and ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>\u2009+\u2009NF group mice were fed a normal specific pathogen-free (SPF) diet; the ApoE<jats:sup>\u2212\/\u2212<\/jats:sup>\u2009+\u2009HF group mice were fed a high-cholesterol SPF diet. The plasma and jejunum tissue homogenate were obtained for non-targeted lipid metabolomics. The lipid droplets in tissues were observed by transmission electron microscope and oil red O staining. Jejunum tissue morphology was observed by HE staining. The kits were used to detect lipid content in plasma, tissues, intestinal contents, and cells. Western blot, RT-PCR, immunohistochemistry (IHC), and immunofluorescence (IF) were used to observe the key target of lipid metabolism. In vitro, the final concentration of cholesterol was 100\u00a0\u03bcmol\/L in Caco-cells. Oil red O staining, western blot, RT-PCR and immunofluorescence (IF) were used to observe the changes of lipid metabolism. Finally, the influence of liver X receptor alpha (LXR\u03b1) on intestinal cholesterol metabolism was clarified by applying the LXR\u03b1 inhibitor GSK2033 and siRNA targeting LXR\u03b1.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The aortic arch and intestinal villi of the two groups of ApoE<jats:sup>\u2212\/\u2212<\/jats:sup> mice showed apparent lesions and lipid accumulation, and there were significant changes in a variety of lipids in the plasma and jejunum. Additionally, jejunum LXR\u03b1 was markedly activated. High cholesterol can significantly activate LXR\u03b1 in Caco-2 cells. After LXR\u03b1 was inhibited, the protein level of ATP-binding cassette transporter A1\/G5\/G8 (ABCA1\/G5\/G8) decreased, and the quantity and volume of intracellular lipids soared.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In a high-cholesterol environment, the intestine promotes the excretion of cholesterol from the cell through the LXR\u03b1-ABCA1\/G5\/G8 pathway, reduces the intestinal intake of a variety of exogenous cholesterol, and reduces the risk of AS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Graphical Abstract<\/jats:title>\n                \n              <\/jats:sec>","DOI":"10.1186\/s12944-023-01810-6","type":"journal-article","created":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T09:02:09Z","timestamp":1681549329000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Excessive exogenous cholesterol activating intestinal LXR\u03b1-ABCA1\/G5\/G8 signaling pathway can not reverse atherosclerosis in ApoE\u2212\/\u2212 mice"],"prefix":"10.1186","volume":"22","author":[{"given":"Xichao","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunhui","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjun","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,4,15]]},"reference":[{"key":"1810_CR1","doi-asserted-by":"publisher","first-page":"909151","DOI":"10.3389\/fmolb.2022.909151","volume":"9","author":"BH Zhang","year":"2022","unstructured":"Zhang BH, Yin F, Qiao YN, Guo SD. Triglyceride and triglyceride-rich lipoproteins in atherosclerosis. Front Mol Biosci. 2022;9:909151.","journal-title":"Front Mol Biosci"},{"issue":"12","key":"1810_CR2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1136\/jclinpath-2021-207719","volume":"75","author":"AS Wierzbicki","year":"2022","unstructured":"Wierzbicki AS, Kim EJ, Esan O, Ramachandran R. Hypertriglyceridaemia: an update. J Clin Pathol. 2022;75(12):798\u2013806.","journal-title":"J Clin Pathol"},{"issue":"9","key":"1810_CR3","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/s41569-022-00676-y","volume":"19","author":"J Boren","year":"2022","unstructured":"Boren J, Taskinen MR, Bjornson E, Packard CJ. Metabolism of triglyceride-rich lipoproteins in health and dyslipidaemia. Nat Rev Cardiol. 2022;19(9):577\u201392.","journal-title":"Nat Rev Cardiol"},{"issue":"4","key":"1810_CR4","first-page":"461","volume":"40","author":"S Lestavel","year":"1994","unstructured":"Lestavel S, Fruchart JC. Lipoprotein receptors. Cell Mol Biol (Noisy-le-grand). 1994;40(4):461\u201381.","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"issue":"6","key":"1810_CR5","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1253\/circj.CJ-20-0051","volume":"84","author":"AY Jang","year":"2020","unstructured":"Jang AY, Han SH, Sohn IS, Oh PC, Koh KK. Lipoprotein(a) and cardiovascular diseases - revisited. Circ J. 2020;84(6):867\u201374.","journal-title":"Circ J"},{"issue":"4","key":"1810_CR6","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/S1474-4422(21)00376-8","volume":"21","author":"J Gutierrez","year":"2022","unstructured":"Gutierrez J, Turan TN, Hoh BL, Chimowitz MI. Intracranial atherosclerotic stenosis: risk factors, diagnosis, and treatment. Lancet Neurol. 2022;21(4):355\u201368.","journal-title":"Lancet Neurol"},{"issue":"8","key":"1810_CR7","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41574-018-0037-x","volume":"14","author":"B Wang","year":"2018","unstructured":"Wang B, Tontonoz P. Liver X receptors in lipid signalling and membrane homeostasis. Nat Rev Endocrinol. 2018;14(8):452\u201363.","journal-title":"Nat Rev Endocrinol"},{"issue":"7","key":"1810_CR8","doi-asserted-by":"publisher","first-page":"4807","DOI":"10.1002\/jcp.30204","volume":"236","author":"L Zhao","year":"2021","unstructured":"Zhao L, Lei W, Deng C, Wu Z, Sun M, Jin Z, Song Y, Yang Z, Jiang S, Shen M, et al. The roles of liver X receptor alpha in inflammation and inflammation-associated diseases. J Cell Physiol. 2021;236(7):4807\u201328.","journal-title":"J Cell Physiol"},{"issue":"4","key":"1810_CR9","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1080\/10409238.2021.1925217","volume":"56","author":"AG Groenen","year":"2021","unstructured":"Groenen AG, Halmos B, Tall AR, Westerterp M. Cholesterol efflux pathways, inflammation, and atherosclerosis. Crit Rev Biochem Mol Biol. 2021;56(4):426\u201339.","journal-title":"Crit Rev Biochem Mol Biol"},{"issue":"3","key":"1810_CR10","first-page":"893","volume":"44","author":"Q Jia","year":"2019","unstructured":"Jia Q, Cao H, Shen D, Li S, Yan L, Chen C, Xing S, Dou F. Quercetin protects against atherosclerosis by regulating the expression of PCSK9, CD36, PPARgamma, LXRalpha and ABCA1. Int J Mol Med. 2019;44(3):893\u2013902.","journal-title":"Int J Mol Med"},{"issue":"13","key":"1810_CR11","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.febslet.2010.03.030","volume":"584","author":"JL Betters","year":"2010","unstructured":"Betters JL, Yu L. NPC1L1 and cholesterol transport. FEBS Lett. 2010;584(13):2740\u20137.","journal-title":"FEBS Lett"},{"issue":"10","key":"1810_CR12","doi-asserted-by":"publisher","first-page":"917","DOI":"10.1080\/13543784.2019.1657825","volume":"28","author":"L Chen","year":"2019","unstructured":"Chen L, Duan Y, Wei H, Ning H, Bi C, Zhao Y, Qin Y, Li Y. Acetyl-CoA carboxylase (ACC) as a therapeutic target for metabolic syndrome and recent developments in ACC1\/2 inhibitors. Expert Opin Investig Drugs. 2019;28(10):917\u201330.","journal-title":"Expert Opin Investig Drugs"},{"issue":"15","key":"1810_CR13","doi-asserted-by":"publisher","first-page":"9502","DOI":"10.1021\/acs.chemrev.1c00147","volume":"121","author":"P Paiva","year":"2021","unstructured":"Paiva P, Medina FE, Viegas M, Ferreira P, Neves RPP, Sousa JPM, Ramos MJ, Fernandes PA. Animal fatty acid synthase: a chemical nanofactory. Chem Rev. 2021;121(15):9502\u201353.","journal-title":"Chem Rev"},{"issue":"11","key":"1810_CR14","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.biochi.2004.09.018","volume":"86","author":"D Eberle","year":"2004","unstructured":"Eberle D, Hegarty B, Bossard P, Ferre P, Foufelle F. SREBP transcription factors: master regulators of lipid homeostasis. Biochimie. 2004;86(11):839\u201348.","journal-title":"Biochimie"},{"key":"1810_CR15","doi-asserted-by":"publisher","first-page":"101919","DOI":"10.1016\/j.redox.2021.101919","volume":"41","author":"S Zhong","year":"2021","unstructured":"Zhong S, Li L, Liang N, Zhang L, Xu X, Chen S, Yin H. Acetaldehyde Dehydrogenase 2 regulates HMG-CoA reductase stability and cholesterol synthesis in the liver. Redox Biol. 2021;41:101919.","journal-title":"Redox Biol"},{"key":"1810_CR16","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.cca.2021.06.029","volume":"521","author":"X Su","year":"2021","unstructured":"Su X, Chen X, Wang B. Pathology of metabolically-related dyslipidemia. Clin Chim Acta. 2021;521:107\u201315.","journal-title":"Clin Chim Acta"},{"issue":"8","key":"1810_CR17","doi-asserted-by":"publisher","first-page":"739","DOI":"10.3390\/metabo12080739","volume":"12","author":"OE Alboniga","year":"2022","unstructured":"Alboniga OE, Gonzalez-Mendia O, Blanco ME, Alonso RM. HPLC-(Q)-TOF-MS-based study of plasma metabolic profile differences associated with age in pediatric population using an animal model. Metabolites. 2022;12(8):739.","journal-title":"Metabolites"},{"issue":"4","key":"1810_CR18","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/s40256-020-00421-1","volume":"20","author":"YN Lamb","year":"2020","unstructured":"Lamb YN. Rosuvastatin\/Ezetimibe: a review in hypercholesterolemia. Am J Cardiovasc Drugs. 2020;20(4):381\u201392.","journal-title":"Am J Cardiovasc Drugs"},{"issue":"6","key":"1810_CR19","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1001\/jama.290.6.765","volume":"290","author":"PO Szapary","year":"2003","unstructured":"Szapary PO, Wolfe ML, Bloedon LT, Cucchiara AJ, DerMarderosian AH, Cirigliano MD, Rader DJ. Guggulipid for the treatment of hypercholesterolemia: a randomized controlled trial. JAMA. 2003;290(6):765\u201372.","journal-title":"JAMA"},{"issue":"1","key":"1810_CR20","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s12944-021-01596-5","volume":"20","author":"M Tang","year":"2021","unstructured":"Tang M, Song C, Zhang Y, Xu X, Wang C, Zhang Z, Chen T. Levels of pretreatment blood lipids are prognostic factors in advanced NSCLC patients treated with anlotinib. Lipids Health Dis. 2021;20(1):165.","journal-title":"Lipids Health Dis"},{"issue":"2","key":"1810_CR21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1002\/ptr.2911","volume":"24","author":"K Matsumoto","year":"2010","unstructured":"Matsumoto K, Yokoyama S, Gato N. Bile acid-binding activity of young persimmon (Diospyros kaki) fruit and its hypolipidemic effect in mice. Phytother Res. 2010;24(2):205\u201310.","journal-title":"Phytother Res"},{"key":"1810_CR22","doi-asserted-by":"publisher","first-page":"154120","DOI":"10.1016\/j.phymed.2022.154120","volume":"101","author":"Y Fu","year":"2022","unstructured":"Fu Y, Feng H, Ding X, Meng QH, Zhang SR, Li J, Chao Y, Ji TT, Bi YH, Zhang WW, et al. Alisol B 23-acetate adjusts bile acid metabolisim via hepatic FXR-BSEP signaling activation to alleviate atherosclerosis. Phytomedicine. 2022;101:154120.","journal-title":"Phytomedicine"},{"issue":"1","key":"1810_CR23","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/19490976.2021.1880220","volume":"13","author":"Q Meng","year":"2021","unstructured":"Meng Q, Ma M, Zhang W, Bi Y, Cheng P, Yu X, Fu Y, Chao Y, Ji T, Li J, et al. The gut microbiota during the progression of atherosclerosis in the perimenopausal period shows specific compositional changes and significant correlations with circulating lipid metabolites. Gut Microbes. 2021;13(1):1\u201327.","journal-title":"Gut Microbes"}],"container-title":["Lipids in Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01810-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12944-023-01810-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12944-023-01810-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,15]],"date-time":"2023-04-15T09:02:12Z","timestamp":1681549332000},"score":1,"resource":{"primary":{"URL":"https:\/\/lipidworld.biomedcentral.com\/articles\/10.1186\/s12944-023-01810-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,15]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1810"],"URL":"https:\/\/doi.org\/10.1186\/s12944-023-01810-6","relation":{},"ISSN":["1476-511X"],"issn-type":[{"value":"1476-511X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,4,15]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 April 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Animal experiments strictly abide by the \"Guidelines for the Management and Use of Laboratory Animals\" issued by the National Science and Technology Publication Committee (issued in May 2018). The experimental protocol was approved by the Animal Ethics Committee of Nanjing University of Traditional Chinese Medicine. The mice were sacrificed by intraperitoneal injection of five times the anesthesia dose of sodium pentobarbital (45\u00a0mg\/kg, 0.5\u00a0ml\/10\u00a0g).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"51"}}